Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,870 | 46,656 | 59,884 | 57,649 | 82,045 |
| Marketable Securities | 157,997 | 114,122 | 106,778 | 104,434 | 63,764 |
| Receivables | 25,976 | 473 | 884 | 50 | 228 |
| Other current assets | 2,208 | 1,412 | 1,390 | 1,252 | 922 |
| TOTAL | $262,718 | $167,997 | $172,161 | $165,817 | $148,802 |
| Non-Current Assets | |||||
| PPE Net | 14,829 | 13,977 | 11,548 | 11,524 | 11,061 |
| Investments And Advances | 5,917 | 15,616 | 24,485 | 46,417 | 63,742 |
| Other Non-Current Assets | 33,753 | 1,087 | 1,061 | 618 | 522 |
| TOTAL | $54,499 | $30,680 | $37,094 | $58,559 | $75,325 |
| Total Assets | $317,217 | $198,677 | $209,255 | $224,376 | $224,127 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,007 | 4,832 | 2,594 | 3,948 | 4,129 |
| Accrued Expenses | 9,869 | 9,605 | 10,805 | 7,514 | 5,829 |
| TOTAL | $14,876 | $14,437 | $13,399 | $11,462 | $9,958 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,776 | 0 | 0 | 0 | 0 |
| TOTAL | $3,001 | $1,211 | $1,205 | $1,217 | $1,271 |
| Total Liabilities | $17,877 | $15,648 | $14,604 | $12,679 | $11,229 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,936 | 31,655 | 31,145 | 30,894 | 30,821 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -78,714 | -187,756 | -171,759 | -151,053 | -136,580 |
| Other shareholders' equity | -903 | -715 | -553 | -646 | -572 |
| TOTAL | $299,340 | $183,029 | $194,651 | $211,697 | $212,898 |
| Total Liabilities And Equity | $317,217 | $198,677 | $209,255 | $224,376 | $224,127 |